Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 54.5%
Negative

Neutral
PRNewsWire
3 days ago
The Boat House Named Exclusive Bennington Pontoon Dealer for Collier County, Florida
The Boat House, the #1 Bennington dealer in Wisconsin, brings its full-service Bennington program to Collier County as the brand's exclusive authorized dealer NAPLES, Fla., May 27, 2026 /PRNewswire/ -- The Boat House, a 5 Star Certified MRAA dealer group operating 10 locations across Southwest Florida and the Midwest, has been named the exclusive authorized dealer for Bennington Pontoon Boats in Collier County, Florida, effective July 1, 2026.
The Boat House Named Exclusive Bennington Pontoon Dealer for Collier County, Florida
Neutral
PRNewsWire
10 days ago
Polaris Publishes 2025 Geared For Good Report
Annual report highlights progress across product innovation, environmental stewardship, community impact and employee development MINNEAPOLIS, May 21, 2026 /PRNewswire/ -- Polaris Inc. (NYSE: PII) today released its 2025 Geared For Good Report. The annual report highlights Polaris' ongoing efforts to support its people, riders, communities and the outdoors while advancing toward its 2035 environmental goals.
Polaris Publishes 2025 Geared For Good Report
Positive
Zacks Investment Research
15 days ago
3 Top-Ranked Mid-Cap Outdoor Industry Stocks for a Strong Portfolio
COLM, PII and VFC stand out as top-ranked mid-cap outdoor stocks backed by brand strength, growth strategies and improving earnings estimates.
3 Top-Ranked Mid-Cap Outdoor Industry Stocks for a Strong Portfolio
Neutral
Business Wire
17 days ago
Encoded Therapeutics Presents New Clinical Data from POLARIS Phase 1/2 Trials of ETX101 Gene Therapy in Dravet Syndrome at the ASGCT 2026 Presidential Symposium
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #ASGCT2026--Encoded Therapeutics, Inc. (“Encoded”), a clinical‑stage biotechnology company developing precision genetic medicines for severe neurological disorders, today will present an expanded dataset from the ongoing POLARIS Phase 1/2 trials of ETX101, its investigational AAV9‑based gene regulation therapy designed as a one‑time, disease‑modifying treatment for SCN1A+ Dravet syndrome. The update includes additional patients, early data from the top dose lev.
Encoded Therapeutics Presents New Clinical Data from POLARIS Phase 1/2 Trials of ETX101 Gene Therapy in Dravet Syndrome at the ASGCT 2026 Presidential Symposium
Neutral
Business Wire
18 days ago
Behavox Extends Polaris Trade Surveillance to Prediction Markets, Expanding Risk Coverage to 10 Asset Classes
LONDON & MONTREAL--(BUSINESS WIRE)--Behavox, an AI company providing unified controls frameworks for financial institutions, today announced that Polaris, its trade surveillance platform, now covers prediction markets as a new asset class — bringing Polaris's out-of-the-box risk coverage to 10 asset classes. Prediction markets coverage is available in beta to existing Polaris customers immediately, with general availability scheduled for summer 2026. "We are getting consistent feedback from cus.
Behavox Extends Polaris Trade Surveillance to Prediction Markets, Expanding Risk Coverage to 10 Asset Classes
Neutral
PRNewsWire
26 days ago
Polaris Declares Regular Cash Dividend
MINNEAPOLIS, May 4, 2026 /PRNewswire/ -- Polaris Inc. (NYSE: PII) announced today that its Board of Directors has declared a regular quarterly cash dividend of $0.68 per share payable on June 15, 2026 to shareholders of record at the close of business on June 1, 2026. About Polaris  As the global leader in powersports, Polaris Inc. (NYSE: PII) has been defining and redefining outdoor adventure since 1954.
Polaris Declares Regular Cash Dividend
Positive
The Motley Fool
27 days ago
Did Polaris Just Turn Into a Drone Stock?
ATV maker Polaris beat analyst forecasts this week -- but still lost a lot of money. 2026 sales could flatline, but a new business manufacturing ground drones with Forterra might reignite sales growth.
Did Polaris Just Turn Into a Drone Stock?
Neutral
Seeking Alpha
1 month ago
Polaris Inc. (PII) Q1 2026 Earnings Call Transcript
Polaris Inc. (PII) Q1 2026 Earnings Call Transcript
Polaris Inc. (PII) Q1 2026 Earnings Call Transcript
Positive
Zacks Investment Research
1 month ago
Here's What Key Metrics Tell Us About Polaris Inc (PII) Q1 Earnings
Although the revenue and EPS for Polaris Inc (PII) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Here's What Key Metrics Tell Us About Polaris Inc (PII) Q1 Earnings
Positive
Zacks Investment Research
1 month ago
Polaris Inc (PII) Q1 Earnings and Revenues Beat Estimates
Polaris Inc (PII) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of a loss of $0.43 per share. This compares to a loss of $0.9 per share a year ago.
Polaris Inc (PII) Q1 Earnings and Revenues Beat Estimates